DD294944A5 - Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen - Google Patents

Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen Download PDF

Info

Publication number
DD294944A5
DD294944A5 DD90341316A DD34131690A DD294944A5 DD 294944 A5 DD294944 A5 DD 294944A5 DD 90341316 A DD90341316 A DD 90341316A DD 34131690 A DD34131690 A DD 34131690A DD 294944 A5 DD294944 A5 DD 294944A5
Authority
DD
German Democratic Republic
Prior art keywords
triazolo
pyrazine
methylamino
fluorobenzyl
group
Prior art date
Application number
DD90341316A
Other languages
German (de)
English (en)
Inventor
James L Kelley
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD294944A5 publication Critical patent/DD294944A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD90341316A 1989-06-06 1990-06-05 Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen DD294944A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913011A GB8913011D0 (en) 1989-06-06 1989-06-06 Anticonvulsant pyrazines

Publications (1)

Publication Number Publication Date
DD294944A5 true DD294944A5 (de) 1991-10-17

Family

ID=10657983

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90341316A DD294944A5 (de) 1989-06-06 1990-06-05 Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen

Country Status (11)

Country Link
US (1) US5095018A (fr)
EP (1) EP0402096B1 (fr)
JP (1) JP3027762B2 (fr)
AT (1) ATE141604T1 (fr)
AU (1) AU628581B2 (fr)
CA (1) CA2018308C (fr)
DD (1) DD294944A5 (fr)
DE (1) DE69028147T2 (fr)
ES (1) ES2091796T3 (fr)
GB (1) GB8913011D0 (fr)
NZ (1) NZ233928A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL310386A1 (en) * 1993-02-22 1995-12-11 Merck & Co Inc Antagonists of factor i receptors
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
CN1285834A (zh) * 1997-11-11 2001-02-28 小野药品工业株式会社 稠合吡嗪化合物
WO2011082267A2 (fr) * 2009-12-30 2011-07-07 Arqule, Inc. Composés triazolo-pyrazine substitués

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1146770A (en) * 1967-02-03 1969-03-26 Ici Ltd S-triazolo[4,3-a]pyrazine derivatives
JPS5129766B2 (fr) * 1971-10-04 1976-08-27
US4056632A (en) * 1975-07-21 1977-11-01 Burroughs Wellcome Co. 2-Hydroxymethyl-2'-aminomethyl-diphenylsulfides and method of use
US3997540A (en) * 1975-07-21 1976-12-14 Burroughs Wellcome Co. O [(O-piperazinocarbonyl-phenyl)-thio]-benzoates
US4438266A (en) * 1982-05-17 1984-03-20 Merck & Co., Inc. Triazolopyrazinamines useful as adjuncts to radiation therapy
GB8408615D0 (en) * 1984-04-04 1984-05-16 Wellcome Found Heterocyclic compounds
MC1673A1 (fr) * 1984-06-27 1986-06-03 Wellcome Found Derives aryliques de composes imidazoliques,leur preparation et leur emploi pour la preparation des medicaments

Also Published As

Publication number Publication date
CA2018308C (fr) 2000-08-01
AU628581B2 (en) 1992-09-17
NZ233928A (en) 1992-10-28
JPH0320276A (ja) 1991-01-29
EP0402096A2 (fr) 1990-12-12
EP0402096A3 (fr) 1991-09-18
DE69028147D1 (de) 1996-09-26
ATE141604T1 (de) 1996-09-15
CA2018308A1 (fr) 1990-12-06
ES2091796T3 (es) 1996-11-16
AU5684290A (en) 1990-12-13
US5095018A (en) 1992-03-10
JP3027762B2 (ja) 2000-04-04
EP0402096B1 (fr) 1996-08-21
GB8913011D0 (en) 1989-07-26
DE69028147T2 (de) 1997-01-02

Similar Documents

Publication Publication Date Title
DE69304076T2 (de) N-cyano-n'-pyridylguanidine als serotoninantagonisten
DD151309A5 (de) Verfahren zur herstellung von substituierten aminotriazinen
DD291560A5 (de) Verfahren zum herstellen von racemischen oder optisch aktiven pyrido [1,2-a] pyrazin-derivaten
EP0063381A1 (fr) Pyrazolo(3,4-d) pyrimidines, procédé pour leur préparation et compositions pharmaceutiques les contenant
EP1032574B1 (fr) Composes indolo 2,1-b|quinazole-6,12-dione antipaludiques et leurs modalites d'utilisation
DD298400A5 (de) 5-alkylchinoloncarbonsaeuren
DD224033A5 (de) Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze
DE10202468A1 (de) Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
EP1296986B1 (fr) 5-aminoalkyle-pyrazolo[4,3-d]pyrimidines a effet inhibant la phosphosdiesterase v
DE60026883T2 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
EP1485057B9 (fr) Derives de composes azaspiro pour le traitement de la douleur
EP0317855B1 (fr) Produits pharmaceutiques
DD294944A5 (de) Verfahren zur herstellung von 1,2,4-triazolo[4,3-a]pyrazinen
DE3035688C2 (fr)
DE68902490T2 (de) Pharmazeutische zusammensetzung.
EP0409125A1 (fr) Sels de l'acide N5, N10-méthylène-5,6,7,8-tétrahydrofolique
CH637391A5 (de) Therapeutisch wirksame 3-(1-piperazinyl)-1,2,4-benzotriazine und ihre n-oxide.
EP0280290B1 (fr) Remède à activité antidépressive
DE68911951T2 (de) 5-(Substituierte Amino)-8-(phenyl oder substituierte phenyl)-3H,6H-1,4,5a,8a-tetraazaacenaphthylen-3-one.
DE69013396T2 (de) Triazolo[4,5-c]pyridinderivate mit krampflindernder Wirkung.
DE2420779A1 (de) 3-substituierte 4,5-dihydro-1,2,4oxadiazole
DE10320732A1 (de) Neue schnell wirkende Anästhetika und Verfahren zu ihrer Herstellung
DE4419973A1 (de) Monohydratform des (R)-2-Cycloheptylmethylaminomethyl-8-methoxy-chroman-hydrochlorids
DE3823345A1 (de) 6-merkaptopurin-derivate, ihre herstellung und ihre verwendung zur bekaempfung von retrovirusinfektionen
EP0111205B1 (fr) Dérivés d'acridanone

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee